Oncimmune Holdings Valuation
| ONC Stock | 15.20 0.45 3.05% |
At this time, the company appears to be overvalued. Oncimmune Holdings plc holds a recent Real Value of USD14.1 per share. The prevailing price of the company is USD15.2. Our model determines the value of Oncimmune Holdings plc from analyzing the company fundamentals such as Operating Margin of (0.64) %, shares outstanding of 111.77 M, and Return On Equity of -7.61 as well as examining its technical indicators and probability of bankruptcy.
Price Book 49.2727 | Enterprise Value 20.8 M | Enterprise Value Ebitda (5.12) | Price Sales 14.0421 | Forward PE 73.5294 |
Overvalued
Today
Please note that Oncimmune Holdings' price fluctuation is somewhat reliable at this time. Calculation of the real value of Oncimmune Holdings plc is based on 3 months time horizon. Increasing Oncimmune Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Oncimmune stock is determined by what a typical buyer is willing to pay for full or partial control of Oncimmune Holdings plc. Since Oncimmune Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oncimmune Stock. However, Oncimmune Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.2 | Real 14.1 | Hype 15.2 | Naive 14.51 |
The real value of Oncimmune Stock, also known as its intrinsic value, is the underlying worth of Oncimmune Holdings plc Company, which is reflected in its stock price. It is based on Oncimmune Holdings' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Oncimmune Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Oncimmune Holdings plc helps investors to forecast how Oncimmune stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oncimmune Holdings more accurately as focusing exclusively on Oncimmune Holdings' fundamentals will not take into account other important factors: Oncimmune Holdings Cash |
|
Oncimmune Holdings Total Value Analysis
Oncimmune Holdings plc is now forecasted to have takeover price of 20.84 M with market capitalization of 17.05 M, debt of 5.3 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Oncimmune Holdings fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
20.84 M | 17.05 M | 5.3 M |
Oncimmune Holdings Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Oncimmune Holdings plc had not issued any dividends in recent years. Based on the key indicators related to Oncimmune Holdings' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Oncimmune Holdings plc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Oncimmune Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Oncimmune Holdings has an asset utilization ratio of 13.66 percent. This indicates that the Company is making USD0.14 for each dollar of assets. An increasing asset utilization means that Oncimmune Holdings plc is more efficient with each dollar of assets it utilizes for everyday operations.Oncimmune Holdings Ownership Allocation
Oncimmune Holdings owns a total of 111.77 Million outstanding shares. Oncimmune Holdings has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Oncimmune Holdings Profitability Analysis
The company reported the revenue of 1.15 M. Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 1.46 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Oncimmune Holdings' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Oncimmune Holdings and how it compares across the competition.
About Oncimmune Holdings Valuation
The stock valuation mechanism determines Oncimmune Holdings' current worth on a weekly basis. Our valuation model uses a comparative analysis of Oncimmune Holdings. We calculate exposure to Oncimmune Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Oncimmune Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 910.8 K | 716.4 K |
Complementary Tools for Oncimmune Stock analysis
When running Oncimmune Holdings' price analysis, check to measure Oncimmune Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncimmune Holdings is operating at the current time. Most of Oncimmune Holdings' value examination focuses on studying past and present price action to predict the probability of Oncimmune Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncimmune Holdings' price. Additionally, you may evaluate how the addition of Oncimmune Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |